Quantcast

UVA Artificial Pancreas Research Receives $3.4 Million Grant - NBC29 WVIR Charlottesville, VA News, Sports and Weather

UVA Artificial Pancreas Research Receives $3.4 Million Grant

Posted: Updated:
Artificial pancreas on smartphone Artificial pancreas on smartphone

A high-tech project at the University of Virginia to turn an ordinary smartphone into an artificial pancreas is getting a financial boost.

The National Institute of Health has awarded a $3.4 million grant to the research. Researchers are working to make the smartphone control a patient's insulin pump. It's been successful in trials so far.

The grant will fund three more clinical trials at UVA and Stanford.

University of Virginia Press Release

Artificial Pancreas Receives $3.4 Million Grant

Cutting-Edge System Aims to Automate Care for People With Type 1 Diabetes

CHARLOTTESVILLE, Va., Nov. 18, 2013 – A high-tech project to turn an ordinary smart phone into an artificial pancreas that could transform the lives of people with type 1 diabetes has received a $3.4 million grant from the National Institutes of Health.

The money will fund a new network approach to artificial pancreas design using distributed computing between local and Cloud systems that will allow real-time adjustment of insulin delivery based on the individual’s needs. The grant will also fund three clinical trials at the University of Virginia and at Stanford University that will advance the project toward its final goal of offering people with type 1 diabetes – in which the body does not produce enough insulin – an automated way to monitor and regulate their blood sugar.

“This project approaches the artificial pancreas not as a single device but as a network of local and global services working seamlessly together towards the optimal control of diabetes,” said Boris Kovatchev, PhD, of the University of Virginia School of Medicine.

Managing Type 1 Diabetes

The artificial pancreas was developed at the School of Medicine by a team of researchers led by Kovatchev, the director of the UVA Center for Diabetes Technology, and Patrick Keith-Hynes, PhD. The device consists of a reconfigured smart phone running advanced algorithms, linked wirelessly with a blood glucose monitor and an insulin pump, and communicating with Internet services in real time.

The system’s developers intend for it to monitor and regulate blood-sugar levels automatically, report to a remote-monitoring site and link the user with assistance via telemedicine as needed. This would save users from having to stick their fingers to check their glucose levels multiple times a day and eliminate the need for countless syringes to inject insulin manually.

The physicians on the team – Bruce Buckingham, MD, of Stanford, and UVA’s Stacey Anderson, MD, and Sue Brown, MD – have tested the artificial pancreassystem in successful outpatient trials in Virginia, California and in Europe.

Next Steps

The grant money from the National Institutes of Health will enable researchers at UVA to implement a new network approach to the artificial pancreas system known as the Diabetes Assistant (DiAs). Clinicians at UVA and Stanford will then test the artificial pancreas in both adults and children. Adult testing will be done at UVA, while Stanford will conduct the pediatric studies.

About the Artificial Pancreas

The development of the artificial pancreas was supported by Paul and Diane Manning of Charlottesville, the Frederick Banting Foundation of Richmond and by the JDRF’s Artificial Pancreas Project.

The Artificial Pancreas Project has brought together researchers from UVA, Stanford, the University of California, Santa Barbara, Montpellier University Hospital in France and the Universities of Padova and Pavia in Italy.

  • Sign Up for Email Alerts

    Sign up to receive NBC29 news and weather updates in your inbox daily.

    * denotes required fields



    Thank you for signing up! You will receive a confirmation email shortly.
Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and WVIR. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.